Patents by Inventor Paul John Hertzog

Paul John Hertzog has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of diagnosis and treatment
    Patent number: 10441636
    Abstract: The present invention relates generally to a method of diagnosing, prognosing or monitoring the development or progress of metastatic cancer, more particularly bone metastatic cancer. The method of the present invention more particularly provides a method for detecting metastatic cancer, or a predisposition thereto, by screening for the differential expression of a panel of genes which comprise an IRF7 binding site. In a related aspect, the present invention provides a method of therapeutically or prophylactically treating metastatic cancer, in particular bone metastatic cancer. More particularly, the present invention provides a means of therapeutically or prophylactically treating metastatic cancer by upregulating type I IFN levels.
    Type: Grant
    Filed: July 19, 2013
    Date of Patent: October 15, 2019
    Assignee: LA TROBE UNIVERSITY
    Inventors: Belinda Sheree Parker, Paul John Hertzog
  • Method of diagnosis and treatment
    Patent number: 10376565
    Abstract: The present invention relates generally to a method of diagnosing, prognosing or monitoring the development or progress of metastatic cancer, more particularly bone metastatic cancer. The method of the present invention more particularly provides a method for detecting metastatic cancer, or a predisposition thereto, by screening for the differential expression of a panel of genes which comprise an IRF7 binding site. In a related aspect, the present invention provides a method of therapeutically or prophylactically treating metastatic cancer, in particular bone metastatic cancer. More particularly, the present invention provides a means of therapeutically or prophylactically treating metastatic cancer by upregulating type I IFN levels.
    Type: Grant
    Filed: July 19, 2013
    Date of Patent: August 13, 2019
    Assignee: LA TROBE UNIVERSITY
    Inventors: Belinda Sheree Parker, Paul John Hertzog
  • METHOD OF DIAGNOSIS AND TREATMENT
    Publication number: 20150174205
    Abstract: The present invention relates generally to a method of diagnosing, prognosing or monitoring the development or progress of metastatic cancer, more particularly bone metastatic cancer. The method of the present invention more particularly provides a method for detecting metastatic cancer, or a predisposition thereto, by screening for the differential expression of a panel of genes which comprise an IRF7 binding site. In a related aspect, the present invention provides a method of therapeutically or prophylactically treating metastatic cancer, in particular bone metastatic cancer. More particularly, the present invention provides a means of therapeutically or prophylactically treating metastatic cancer by upregulating type I IFN levels.
    Type: Application
    Filed: July 19, 2013
    Publication date: June 25, 2015
    Applicant: LATROBE UNIVERSITY
    Inventors: Belinda Sheree Parker, Paul John Hertzog